Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. It develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneo...
FY 2025
Dec 30, 2025
Q4 2025
Q3 2025
Dec 15, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025